nodes	percent_of_prediction	percent_of_DWPC	metapath
Irinotecan—UGT1A1—Rifampicin—leprosy	0.141	0.159	CbGbCtD
Irinotecan—ABCC1—Rifampicin—leprosy	0.116	0.131	CbGbCtD
Irinotecan—SLCO1B1—Rifampicin—leprosy	0.0979	0.11	CbGbCtD
Irinotecan—ABCC2—Rifampicin—leprosy	0.086	0.0969	CbGbCtD
Irinotecan—CYP3A7—Rifampicin—leprosy	0.0575	0.0647	CbGbCtD
Irinotecan—CYP3A7-CYP3A51P—Rifampicin—leprosy	0.0575	0.0647	CbGbCtD
Irinotecan—CYP2B6—Rifampicin—leprosy	0.0547	0.0616	CbGbCtD
Irinotecan—CYP3A7-CYP3A51P—Dapsone—leprosy	0.0474	0.0534	CbGbCtD
Irinotecan—CYP3A7—Dapsone—leprosy	0.0474	0.0534	CbGbCtD
Irinotecan—CYP3A5—Thalidomide—leprosy	0.0445	0.0501	CbGbCtD
Irinotecan—CYP3A5—Rifampicin—leprosy	0.0431	0.0485	CbGbCtD
Irinotecan—CYP3A5—Dapsone—leprosy	0.0356	0.0401	CbGbCtD
Irinotecan—ABCB1—Rifampicin—leprosy	0.028	0.0316	CbGbCtD
Irinotecan—CYP3A4—Rifampicin—leprosy	0.0168	0.0189	CbGbCtD
Irinotecan—CYP3A4—Dapsone—leprosy	0.0139	0.0156	CbGbCtD
Irinotecan—Thromboembolic event—Thalidomide—leprosy	0.00433	0.0386	CcSEcCtD
Irinotecan—Arterial thrombosis—Thalidomide—leprosy	0.00433	0.0386	CcSEcCtD
Irinotecan—Tumour lysis syndrome—Thalidomide—leprosy	0.0042	0.0374	CcSEcCtD
Irinotecan—Acute leukaemia—Thalidomide—leprosy	0.00408	0.0364	CcSEcCtD
Irinotecan—Lipase increased—Thalidomide—leprosy	0.00396	0.0354	CcSEcCtD
Irinotecan—Intestinal perforation—Thalidomide—leprosy	0.00295	0.0263	CcSEcCtD
Irinotecan—Electrolyte imbalance—Thalidomide—leprosy	0.00279	0.0249	CcSEcCtD
Irinotecan—Peripheral vascular disorder—Thalidomide—leprosy	0.00238	0.0212	CcSEcCtD
Irinotecan—Lymphopenia—Thalidomide—leprosy	0.00228	0.0203	CcSEcCtD
Irinotecan—Febrile neutropenia—Thalidomide—leprosy	0.00194	0.0173	CcSEcCtD
Irinotecan—Enlargement abdomen—Thalidomide—leprosy	0.00194	0.0173	CcSEcCtD
Irinotecan—Serum creatinine increased—Thalidomide—leprosy	0.00189	0.0169	CcSEcCtD
Irinotecan—Hypomagnesaemia—Thalidomide—leprosy	0.00183	0.0164	CcSEcCtD
Irinotecan—Embolism—Thalidomide—leprosy	0.00181	0.0162	CcSEcCtD
Irinotecan—Intestinal obstruction—Thalidomide—leprosy	0.00171	0.0152	CcSEcCtD
Irinotecan—Hepatomegaly—Thalidomide—leprosy	0.00165	0.0147	CcSEcCtD
Irinotecan—Lung disorder—Thalidomide—leprosy	0.00165	0.0147	CcSEcCtD
Irinotecan—Thrombosis—Thalidomide—leprosy	0.00165	0.0147	CcSEcCtD
Irinotecan—Myocardial ischaemia—Thalidomide—leprosy	0.00145	0.0129	CcSEcCtD
Irinotecan—Pancreatitis—Dapsone—leprosy	0.0014	0.0125	CcSEcCtD
Irinotecan—Vasodilation—Thalidomide—leprosy	0.00133	0.0118	CcSEcCtD
Irinotecan—Vasodilation procedure—Thalidomide—leprosy	0.00133	0.0118	CcSEcCtD
Irinotecan—Accidental injury—Thalidomide—leprosy	0.00132	0.0117	CcSEcCtD
Irinotecan—Hyperbilirubinaemia—Thalidomide—leprosy	0.00128	0.0114	CcSEcCtD
Irinotecan—Gait disturbance—Thalidomide—leprosy	0.00119	0.0107	CcSEcCtD
Irinotecan—Phosphatase alkaline increased—Thalidomide—leprosy	0.00117	0.0104	CcSEcCtD
Irinotecan—Pulmonary embolism—Thalidomide—leprosy	0.00117	0.0104	CcSEcCtD
Irinotecan—Colitis—Thalidomide—leprosy	0.00112	0.00998	CcSEcCtD
Irinotecan—Sepsis—Thalidomide—leprosy	0.00101	0.00902	CcSEcCtD
Irinotecan—Thrombophlebitis—Thalidomide—leprosy	0.000977	0.00872	CcSEcCtD
Irinotecan—Blood alkaline phosphatase increased—Thalidomide—leprosy	0.000972	0.00868	CcSEcCtD
Irinotecan—Injury—Thalidomide—leprosy	0.00092	0.00821	CcSEcCtD
Irinotecan—Renal failure acute—Thalidomide—leprosy	0.000916	0.00817	CcSEcCtD
Irinotecan—Dermatitis exfoliative—Thalidomide—leprosy	0.000896	0.008	CcSEcCtD
Irinotecan—Vertigo—Dapsone—leprosy	0.000894	0.00798	CcSEcCtD
Irinotecan—Visual disturbance—Thalidomide—leprosy	0.000892	0.00796	CcSEcCtD
Irinotecan—Cough—Dapsone—leprosy	0.000868	0.00775	CcSEcCtD
Irinotecan—Cerebrovascular accident—Thalidomide—leprosy	0.000863	0.0077	CcSEcCtD
Irinotecan—Hyponatraemia—Thalidomide—leprosy	0.000849	0.00758	CcSEcCtD
Irinotecan—Osteoarthritis—Thalidomide—leprosy	0.000846	0.00755	CcSEcCtD
Irinotecan—Gastrointestinal haemorrhage—Thalidomide—leprosy	0.000846	0.00755	CcSEcCtD
Irinotecan—Cardiac arrest—Thalidomide—leprosy	0.000804	0.00718	CcSEcCtD
Irinotecan—Blood creatinine increased—Thalidomide—leprosy	0.000792	0.00707	CcSEcCtD
Irinotecan—Dehydration—Thalidomide—leprosy	0.000786	0.00702	CcSEcCtD
Irinotecan—Orthostatic hypotension—Thalidomide—leprosy	0.000772	0.00689	CcSEcCtD
Irinotecan—Hypokalaemia—Thalidomide—leprosy	0.00077	0.00687	CcSEcCtD
Irinotecan—Cramp muscle—Thalidomide—leprosy	0.000762	0.00679	CcSEcCtD
Irinotecan—Aspartate aminotransferase increased—Thalidomide—leprosy	0.000762	0.00679	CcSEcCtD
Irinotecan—Abdominal distension—Thalidomide—leprosy	0.000736	0.00657	CcSEcCtD
Irinotecan—Insomnia—Dapsone—leprosy	0.000734	0.00655	CcSEcCtD
Irinotecan—Pancreatitis—Thalidomide—leprosy	0.000717	0.00639	CcSEcCtD
Irinotecan—Angina pectoris—Thalidomide—leprosy	0.000712	0.00635	CcSEcCtD
Irinotecan—Neutropenia—Thalidomide—leprosy	0.000683	0.0061	CcSEcCtD
Irinotecan—Upper respiratory tract infection—Thalidomide—leprosy	0.000679	0.00606	CcSEcCtD
Irinotecan—Gastrointestinal pain—Dapsone—leprosy	0.000664	0.00592	CcSEcCtD
Irinotecan—Weight decreased—Thalidomide—leprosy	0.000661	0.0059	CcSEcCtD
Irinotecan—Pneumonia—Thalidomide—leprosy	0.000656	0.00585	CcSEcCtD
Irinotecan—Acute coronary syndrome—Thalidomide—leprosy	0.000642	0.00573	CcSEcCtD
Irinotecan—Abdominal pain—Dapsone—leprosy	0.000642	0.00573	CcSEcCtD
Irinotecan—Body temperature increased—Dapsone—leprosy	0.000642	0.00573	CcSEcCtD
Irinotecan—Renal failure—Thalidomide—leprosy	0.000641	0.00572	CcSEcCtD
Irinotecan—Myocardial infarction—Thalidomide—leprosy	0.000639	0.0057	CcSEcCtD
Irinotecan—Stomatitis—Thalidomide—leprosy	0.000635	0.00567	CcSEcCtD
Irinotecan—Sweating—Thalidomide—leprosy	0.000625	0.00557	CcSEcCtD
Irinotecan—Bradycardia—Thalidomide—leprosy	0.000596	0.00531	CcSEcCtD
Irinotecan—Rhinitis—Thalidomide—leprosy	0.000587	0.00523	CcSEcCtD
Irinotecan—Visual impairment—Thalidomide—leprosy	0.000564	0.00503	CcSEcCtD
Irinotecan—Cardiac disorder—Thalidomide—leprosy	0.000543	0.00484	CcSEcCtD
Irinotecan—Angiopathy—Thalidomide—leprosy	0.000531	0.00474	CcSEcCtD
Irinotecan—Immune system disorder—Thalidomide—leprosy	0.000528	0.00472	CcSEcCtD
Irinotecan—Mediastinal disorder—Thalidomide—leprosy	0.000527	0.0047	CcSEcCtD
Irinotecan—Chills—Thalidomide—leprosy	0.000525	0.00468	CcSEcCtD
Irinotecan—Arrhythmia—Thalidomide—leprosy	0.000523	0.00466	CcSEcCtD
Irinotecan—Alopecia—Thalidomide—leprosy	0.000517	0.00461	CcSEcCtD
Irinotecan—Vomiting—Dapsone—leprosy	0.000516	0.00461	CcSEcCtD
Irinotecan—Headache—Dapsone—leprosy	0.000509	0.00454	CcSEcCtD
Irinotecan—Flatulence—Thalidomide—leprosy	0.000502	0.00448	CcSEcCtD
Irinotecan—Back pain—Thalidomide—leprosy	0.000493	0.0044	CcSEcCtD
Irinotecan—Muscle spasms—Thalidomide—leprosy	0.00049	0.00437	CcSEcCtD
Irinotecan—Nausea—Dapsone—leprosy	0.000482	0.0043	CcSEcCtD
Irinotecan—Ill-defined disorder—Thalidomide—leprosy	0.000473	0.00422	CcSEcCtD
Irinotecan—Anaemia—Thalidomide—leprosy	0.000471	0.0042	CcSEcCtD
Irinotecan—Malaise—Thalidomide—leprosy	0.000459	0.0041	CcSEcCtD
Irinotecan—Vertigo—Thalidomide—leprosy	0.000458	0.00408	CcSEcCtD
Irinotecan—Syncope—Thalidomide—leprosy	0.000457	0.00408	CcSEcCtD
Irinotecan—Leukopenia—Thalidomide—leprosy	0.000456	0.00407	CcSEcCtD
Irinotecan—Loss of consciousness—Thalidomide—leprosy	0.000448	0.00399	CcSEcCtD
Irinotecan—Cough—Thalidomide—leprosy	0.000444	0.00397	CcSEcCtD
Irinotecan—Hypertension—Thalidomide—leprosy	0.00044	0.00392	CcSEcCtD
Irinotecan—Discomfort—Thalidomide—leprosy	0.000428	0.00382	CcSEcCtD
Irinotecan—Confusional state—Thalidomide—leprosy	0.000419	0.00374	CcSEcCtD
Irinotecan—Oedema—Thalidomide—leprosy	0.000416	0.00371	CcSEcCtD
Irinotecan—Infection—Thalidomide—leprosy	0.000413	0.00368	CcSEcCtD
Irinotecan—Shock—Thalidomide—leprosy	0.000409	0.00365	CcSEcCtD
Irinotecan—Nervous system disorder—Thalidomide—leprosy	0.000408	0.00364	CcSEcCtD
Irinotecan—Thrombocytopenia—Thalidomide—leprosy	0.000407	0.00363	CcSEcCtD
Irinotecan—Hyperhidrosis—Thalidomide—leprosy	0.000402	0.00359	CcSEcCtD
Irinotecan—Anorexia—Thalidomide—leprosy	0.000396	0.00354	CcSEcCtD
Irinotecan—Hypotension—Thalidomide—leprosy	0.000388	0.00347	CcSEcCtD
Irinotecan—Insomnia—Thalidomide—leprosy	0.000376	0.00335	CcSEcCtD
Irinotecan—Paraesthesia—Thalidomide—leprosy	0.000373	0.00333	CcSEcCtD
Irinotecan—Dyspnoea—Thalidomide—leprosy	0.000371	0.00331	CcSEcCtD
Irinotecan—Somnolence—Thalidomide—leprosy	0.00037	0.0033	CcSEcCtD
Irinotecan—Dyspepsia—Thalidomide—leprosy	0.000366	0.00326	CcSEcCtD
Irinotecan—Decreased appetite—Thalidomide—leprosy	0.000361	0.00322	CcSEcCtD
Irinotecan—Gastrointestinal disorder—Thalidomide—leprosy	0.000359	0.0032	CcSEcCtD
Irinotecan—Fatigue—Thalidomide—leprosy	0.000358	0.0032	CcSEcCtD
Irinotecan—Constipation—Thalidomide—leprosy	0.000355	0.00317	CcSEcCtD
Irinotecan—Pain—Thalidomide—leprosy	0.000355	0.00317	CcSEcCtD
Irinotecan—Feeling abnormal—Thalidomide—leprosy	0.000343	0.00306	CcSEcCtD
Irinotecan—Gastrointestinal pain—Thalidomide—leprosy	0.00034	0.00303	CcSEcCtD
Irinotecan—Abdominal pain—Thalidomide—leprosy	0.000329	0.00293	CcSEcCtD
Irinotecan—Body temperature increased—Thalidomide—leprosy	0.000329	0.00293	CcSEcCtD
Irinotecan—Hypersensitivity—Thalidomide—leprosy	0.000306	0.00273	CcSEcCtD
Irinotecan—Asthenia—Thalidomide—leprosy	0.000298	0.00266	CcSEcCtD
Irinotecan—Diarrhoea—Thalidomide—leprosy	0.000284	0.00254	CcSEcCtD
Irinotecan—Dizziness—Thalidomide—leprosy	0.000275	0.00245	CcSEcCtD
Irinotecan—Vomiting—Thalidomide—leprosy	0.000264	0.00236	CcSEcCtD
Irinotecan—Rash—Thalidomide—leprosy	0.000262	0.00234	CcSEcCtD
Irinotecan—Dermatitis—Thalidomide—leprosy	0.000262	0.00234	CcSEcCtD
Irinotecan—Headache—Thalidomide—leprosy	0.00026	0.00232	CcSEcCtD
Irinotecan—Nausea—Thalidomide—leprosy	0.000247	0.0022	CcSEcCtD
